| Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Flutiform 250/10, Druckgasinhalation, Suspension | | 63032 | | 03 | | Flutiform 250/10 | | Druckgasinhalation, Suspension | | R03AK11 | | Formoterol and Fluticasone | | 20.01.2014 | | |
| | Composition | | fluticasoni propionas 250 µg pro dosi, formoteroli fumaras dihydricus 10 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. | | Packungsbestandteile | | Druckgasinhalation | | | | | | | | Principe actif | Concentr. |
|---|
| Fluticasoni Propionas | 250 µg | | Formoteroli Fumaras Dihydricus | 10 µg |
| | BAG: Principe actif | Concentr. |
|---|
| Fluticasoni-17 Propionas | 250 mcg | | Formoteroli Fumaras Dihydricus | 10 mcg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Apafluranum ad Aerosolum | | | Ethanol | 1 mg | | Sodium Cromoglicate | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 120 | 58.69 | 80.25 | B | LS | Non |
|
|
